Replimune Group Ownership | Who Owns Replimune Group?
Replimune Group Ownership Summary
Replimune Group is owned by 103.53% institutional investors, 1.75% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 11.90% of REPL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.66% of its assets in Replimune Group shares.
REPL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Replimune Group | 103.53% | 1.75% | -5.28% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 11.05M | 11.90% | $122.27M |
| Blackrock funding, inc. /de | 8.96M | 9.65% | $99.17M |
| Rtw investments, lp | 7.41M | 7.99% | $82.05M |
| Ridgeback capital investments | 7.31M | 7.88% | $80.93M |
| Blackrock | 4.71M | 7.08% | $42.42M |
| Goldman sachs group | 4.54M | 4.89% | $50.27M |
| State street | 4.44M | 4.78% | $49.15M |
| Suvretta capital management | 4.39M | 4.73% | $48.60M |
| Boxer capital management | 3.98M | 4.29% | $44.09M |
| Vanguard group | 3.78M | 4.10% | $36.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ridgeback capital investments | 7.31M | 100.00% | $80.93M |
| Fcpm iii services b.v. | 2.81M | 4.14% | $31.09M |
| Boxer capital management | 3.98M | 3.32% | $44.09M |
| Opaleye management | 1.38M | 1.39% | $15.33M |
| Ghost tree capital | 450.00K | 1.27% | $4.05M |
| Logos global management lp | 2.50M | 1.19% | $27.68M |
| Sofinnova investments | 1.81M | 1.03% | $16.78M |
| Suvretta capital management | 4.39M | 0.89% | $48.60M |
| Boxer capital | 1.54M | 0.73% | $13.83M |
| Rtw investments, lp | 7.41M | 0.70% | $82.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ridgeback capital investments | 7.31M | 100.00% | 7.31M |
| Boxer capital management | 3.98M | 3.32% | 2.81M |
| Blackrock funding, inc. /de | 8.96M | 0.00% | 2.72M |
| Logos global management lp | 2.50M | 1.19% | 2.50M |
| Braidwell lp | 2.75M | 0.34% | 2.33M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 1.62M | 0.00% | -6.50M |
| Atlas venture life science advisors | - | - | -2.10M |
| Commodore capital lp | - | - | -1.43M |
| Rosalind advisors | - | - | -1.41M |
| Camber capital management lp | - | - | -1.35M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ridgeback capital investments | 7.31M | 100.00% | 7.31M | $80.93M |
| Logos global management lp | 2.50M | 1.19% | 2.50M | $27.68M |
| Boxer capital | 1.54M | 0.73% | 1.54M | $13.83M |
| Opaleye management | 1.38M | 1.39% | 1.38M | $15.33M |
| Artisan partners limited partnership | 973.50K | 0.02% | 973.50K | $10.78M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Global retirement partners | -32.00 |
| Creative financial designs inc /adv | -33.00 |
| Stephens consulting | -35.00 |
| Td private client wealth | -48.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 225 | 8.70% | 96,084,260 | 18.48% | 103 | 1.34% | 147 | 33.64% | 46 | -16.36% |
| Mar 31, 2026 | 65 | -64.67% | 10,497,436 | -86.84% | 11 | 0.15% | 32 | -65.59% | 18 | -67.86% |
| Dec 31, 2025 | 102 | -46.32% | 28,686,776 | -65.39% | 31 | 0.38% | 51 | -52.34% | 33 | -31.25% |
| Sep 30, 2025 | 187 | 3.89% | 82,873,954 | 6.75% | 90 | 1.26% | 105 | 25.00% | 48 | -20.00% |
| Jun 30, 2025 | 189 | 13.17% | 80,918,624 | 7.29% | 88 | 1.08% | 86 | -2.27% | 65 | 35.42% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.50M | 2.66% | -47.85K |
| Vanguard US Total Market Shares ETF | 2.02M | 2.63% | 478.00K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.42M | 2.57% | 444.70K |
| Vanguard Total Stock Mkt Idx Inv | 1.97M | 2.35% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.97M | 2.35% | - |
| iShares Russell 2000 ETF | 2.08M | 2.21% | -24.00K |
| T. Rowe Price Integrated US SmCapGrEq | 1.60M | 1.94% | - |
| T. Rowe Price Health Sciences | 1.43M | 1.73% | -91.78K |
| Artisan International Small-Mid Investor | 1.57M | 1.67% | 965.54K |
| T. Rowe Price New Horizons Tr-Z | 1.28M | 1.66% | 1.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 02, 2026 | Dhingra Kapil | - | Sell | $408.50K |
| Aug 17, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | $132.18K |
| Aug 10, 2026 | Patel Sushil | Chief Executive Officer | Sell | $510.25K |
| Aug 10, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | $148.48K |
| Aug 10, 2026 | Xynos Konstantinos | Chief Medical Officer | Sell | $148.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 1 |
| 2026 Q3 | 2 | 5 |
| 2026 Q2 | - | 8 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 4 |
REPL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools